Respiratory Antiviral Treatment Market Trends Analysis; Influenza Segment to Experience Strong Growth
Respiratory Antiviral Treatment: Introduction
- Antiviral drugs are therapeutics that prevent the development and replication of virus without affecting the host cells. These drugs do not destroy their target virus, as it is an obligatory intracellular parasite. Instead, these inhibit their propagation by deactivating the viral enzymes.
- Antiviral drugs are utilized to treat various types of respiratory conditions such as influenza, bronchiolitis, upper respiratory tract infections (URTI), pneumonia, and measles due to their effectiveness
- Most common antiviral drugs used in the treatment of respiratory diseases includes ribavirin, aciclovir, amantadine, rimantadine, and oseltamivir.
Read Report Overview - https://www.transparencymarketresearch.com/respiratory-antiviral-treatment-market.html
Key Drivers of Global Respiratory Antiviral Treatment Market
- Rise in prevalence of viral respiratory infections in humans and increase in health care expenditure are projected to boost the growth of the global respiratory antiviral treatment market during the forecast period. Respiratory syncytial virus, influenza virus, parainfluenza virus, adenovirus, rhinovirus, and coronavirus belong to the respiratory virus infections group. Increase in number of patients with influenza, coronavirus, upper respiratory tract infections (URTI), and pneumonia is anticipated to fuel the growth of the global respiratory antiviral treatment market from 2020 to 2030. According to the World Health Organization, around 1.9 million people are suffering from coronavirus and 123,126 confirmed death due to coronavirus were recorded to date. According to the Centers for Disease Control and Prevention, pneumonia accounted for around 49,157 deaths in the U.S. in 2017.
- Increase in government initiatives and rise in awareness about viral respiratory infections among the general population fuel the growth of the global respiratory antiviral treatment market. Moreover, rich product pipeline, increase in health care funding, improving health care facilities, and surge in research & development activities are expected to augment the global respiratory antiviral treatment market.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77000
Neuraminidase Inhibitors to Witness High Demand
- In terms of drug class, the global respiratory antiviral treatment market can be classified into nucleoside analogs, neuraminidase inhibitors, ion channel blockers, and fusion protein inhibitors
- The neuraminidase inhibitors segment accounted for the largest share of the global respiratory antiviral treatment market in 2019. The segment is likely to dominate the global market because oseltamivir, zanamivir, and other drugs are most commonly used in the treatment of respiratory diseases. The nucleoside analogs segment is projected to witness significant growth during the forecast period due to increase in use of ribavirin in the treatment of respiratory diseases.
Request for Analysis of the COVID19 Impact on Respiratory Antiviral Treatment Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77000
Influenza Segment to Experience Strong Growth
- Based on disease type, the global respiratory antiviral treatment market can be categorized into influenza, bronchiolitis, upper respiratory tract infections (URTI), pneumonia, measles, and others
- The influenza segment generated the highest revenue in 2019 and the trend is anticipated to continue during the forecast period. This can be attributed to high incidence rate of influenza. According to the Centers for Disease Control and Prevention, around 9.7 million people were suffering from influenza in the U.S. as of October 2019.
Hospital Pharmacies to be Most Promising Segment
- In terms of distribution channel, the global respiratory antiviral treatment market can be divided into hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies was the largest segment in terms of revenue in 2019. The segment is expected to witness strong growth during the forecast period due to increase in number of patients with influenza, bronchiolitis, upper respiratory tract infections (URTI), and pneumonia.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=77000
North America to Dominate Global Respiratory Antiviral Treatment Market
- In terms of region, the global respiratory antiviral treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America dominated the global respiratory antiviral treatment market in 2019 and the trend is likely to continue during the forecast period. High number of patients with influenza, bronchiolitis, upper respiratory tract infections (URTI), and coronavirus; early adoption of new products, and presence of major manufacturers are projected to boost the growth of the respiratory antiviral treatment market in North America during the forecast period.
- The market in Asia Pacific is anticipated to expand at the highest CAGR during the forecast period owing to launch of new products and rise in demand for respiratory antiviral treatment in emerging markets such as India and China.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Transparency Market Research
State Tower,
90 State Street,
Suite 700
Albany NY - 12207United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com